Sitabite DM 10mg/500mg/100mg Tablet ER
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Sitabite DM 10mg/500mg/100mg Tablet ER
Diabelite XR 10mg/500mg/100mg tablets are a combined medication for managing blood glucose. This medication complements diet and exercise to enhance glycemic control in adults with type 2 diabetes. It promotes efficient insulin use, thus reducing blood sugar. Diabelite XR can be administered with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their consultation, as abrupt cessation can elevate blood sugar, increasing risks like kidney impairment and vision loss. This medication is part of a comprehensive treatment plan that includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include upper respiratory infection, nasal congestion, sore throat, and urinary tract infection. Adequate hydration is crucial to prevent dehydration. Genital fungal infections are a possibility; good hygiene helps mitigate this risk. Before starting Diabelite XR, inform your doctor about kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or nursing individuals should consult their doctor. Limit alcohol consumption as it may intensify side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Sitabite DM 10mg/500mg/100mg Tablet ER
Managing type 2 diabetes
Major Benefits of Sitabite DM 10mg/500mg/100mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Sitabite DM 10mg/500mg/100mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended for optimal results.
Common Side effects of Sitabite DM 10mg/500mg/100mg Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Sitabite DM 10mg/500mg/100mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitabite DM 10mg/500mg/100mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
How Sitabite DM 10mg/500mg/100mg Tablet ER works:
Sitabite DM 10mg/500mg/100mg Extended-Release tablets combine three antihyperglycemic agents. Dapagliflozin enhances glucose elimination via the kidneys, lowering blood glucose. Metformin reduces intestinal glucose absorption and hepatic glucose production. Furthermore, metformin improves insulin sensitivity, augmenting the body's natural blood sugar regulation. Sitagliptin regulates blood sugar by boosting incretin levels, stimulating insulin release from the pancreas and suppressing excessive hepatic glucose synthesis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sitabite DM 10mg/500mg/100mg Tablet ER is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Sitabite DM 10mg/500mg/100mg Extended-Release Tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Sitabite DM 10mg/500mg/100mg Extended-Release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Sitabite DM 10mg/500mg/100mg Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sitabite DM 10mg/500mg/100mg Extended-Release Tablets in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sitabite DM 10mg/500mg/100mg Extended-Release Tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sitabite DM 10mg/500mg/100mg Tablet ER :
NA
Facts to Know About Sitabite DM 10mg/500mg/100mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |



